BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38688590)

  • 1. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Kazama K; Komori K; Kato A; Otani K; Tamagawa A; Cho H; Morita J; Kawahara S; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    In Vivo; 2024; 38(3):1253-1259. PubMed ID: 38688590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage-Dependent Changes in Albumin, NLR, PLR, and AFR are Correlated with Shorter Survival in Patients with Gastric Cancer.
    Liu C; Li X
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
    Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer.
    Yu W; Ye Z; Fang X; Jiang X; Jiang Y
    J Ovarian Res; 2019 Sep; 12(1):88. PubMed ID: 31533857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
    Ying J; Zhou D; Gu T; Huang J; Liu H
    BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Change in the Fibrinogen and Albumin Score During Preoperative Treatment in Esophageal Cancer Patients.
    Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Suda K; Wada N; Kitagawa Y
    World J Surg; 2017 Nov; 41(11):2788-2795. PubMed ID: 28608015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Immune and Nutritional Indices Are Independent Prognostic Factors for Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kato A; Kazama K; Tamagawa A; Cho H; Nakazono M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
    Anticancer Res; 2024 May; 44(5):2185-2192. PubMed ID: 38677744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis.
    Sun DW; An L; Lv GY
    World J Surg Oncol; 2020 Jan; 18(1):9. PubMed ID: 31931816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma.
    Sun SY; Chen PP; Meng LX; Li L; Mo ZX; Sun CH; Wang Y; Liang FH
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29905761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.
    Suzuki T; Shimada H; Nanami T; Oshima Y; Yajima S; Washizawa N; Kaneko H
    Int J Clin Oncol; 2017 Jun; 22(3):461-468. PubMed ID: 28064398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
    Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
    Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
    Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment Albumin-to-Fibrinogen Ratio is a Promising Biomarker for Predicting Postoperative Clinical Outcomes in Patients with Colorectal Cancer.
    Xie H; Yuan G; Liu M; Huang S; Wei L; Tang S; Gan J
    Nutr Cancer; 2022; 74(8):2896-2909. PubMed ID: 35193433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of the Preoperative Albumin/Fibrinogen Ratio in Patients with Esophageal Squamous Cell Carcinoma after Surgical Resection.
    Zhang H; Ren P; Ma M; Zhu X; Zhu K; Xiao W; Gong L; Tang P; Yu Z
    J Cancer; 2021; 12(16):5025-5034. PubMed ID: 34234871
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic significance of preoperative albumin to fibrinogen ratio associated nomograms in patients with breast invasive ductal carcinoma.
    Zheng L; Zhao Y; Liu F; Liu P; Li W; Yang Y; Zhang H; Liu Y
    Medicine (Baltimore); 2020 Jun; 99(26):e20681. PubMed ID: 32590741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.